Literature DB >> 10229433

Plain radiographs as an outcome measure in ankylosing spondylitis.

D van der Heijde1, A Spoorenberg.   

Abstract

Radiographic evidence of sacroiliitis is a prerequisite for classification according to the (modified) New York criteria. Structural damage is also an important endpoint in the assessment of ankylosing spondylitis (AS). However, little research has been done on the development, validation, and application of scoring methods for radiographic changes in AS. Methodological issues that can be addressed concerning radiographic scoring methods are discussed in detail. A short introduction to the available scoring methods is presented.

Entities:  

Mesh:

Year:  1999        PMID: 10229433

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

Authors:  Zrinka Jajić; Ivana Rajnpreht; Nataša Kovačić; Ivan Krešimir Lukić; Vedran Velagić; Frane Grubišić; Ana Marušić; Danka Grčević
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

2.  The relationship between severity and extent of spinal involvement and spinal mobility and physical functioning in patients with ankylosing spondylitis.

Authors:  Taciser Kaya; Fazil Gelal; Rezzan Gunaydin
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

Review 3.  Treatment trials in ankylosing spondylitis: current and future considerations.

Authors:  D van der Heijde; J Braun; D McGonagle; J Siegel
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

4.  Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan.

Authors:  James Cheng-Chung Wei; Ruey-Hong Wong; Jun-Huang Huang; Chen-Tung Yu; Chung-Tei Chou; Ming-Shiou Jan; Gregory J Tsay; Ming-Chih Chou; Hong-Shen Lee
Journal:  Clin Rheumatol       Date:  2007-02-08       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.